During the past decade, Nanjing Bayi Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nanjing Bayi Hospital" #1 sponsor was "Pfizer" with 6 trials, followed by "BeiGene" with 1 trials sponsored, "Jiangsu HengRui Medicine Co., Ltd." with 1 trials sponsored, "Merck KGaA, Darmstadt, Germany" with 1 trials sponsored and "National Cancer Centre, Singapore" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nanjing Bayi Hospital" #1 collaborator was "Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Singapore Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nanjing Bayi Hospital" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Breast Cancer" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors" (1 trials) and "Gastrointestinal Stromal Tumor" (1 trials). Many other conditions were trialed in "Nanjing Bayi Hospital" in a lesser frequency.

Most popular intervention types in "Nanjing Bayi Hospital" are "Drug" (10 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sorafenib" (3 trials), "PF-02341066" (2 trials), "sunitinib" (2 trials), "Axitinib (AG-013736)" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nanjing Bayi Hospital" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Nanjing Bayi Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Nanjing Bayi Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nanjing Bayi Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".